On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridaySep 30, 2011 5:05 pm

Strategic American Oil Corp. (SGCA) is “One to Watch”

Strategic American Oil Corp. is an oil and natural gas exploration and production company with operations in Texas, Louisiana, and Illinois. Leveraging its technical expertise, promising portfolio and strong financial condition, the company is in an advantageous position to experience remarkable growth in the near term future by aggressively leasing, drilling, and acquiring projects at various stages of development. To date, Strategic American Oil has established a land portfolio with an aggregate gross 5,236 developed and undeveloped acres in Texas and Illinois alone. With this acreage, the company has identified new exploration targets and is applying advanced technology to maximize…

Continue Reading

FridaySep 30, 2011 3:30 pm

Threshold Pharmaceuticals, Inc. (THLD) Announces Initiation of Phase 3 TH-302 Combination Trial for Patients with Advanced Tissue Sarcoma

Threshold Pharmaceuticals, Inc., in partnership with Sarcoma Alliance for Research through Collaboration (SARC), has announced the initiation of a Phase 3 randomized clinical trial of TH-302 in patients with soft tissue sarcoma. This pivotal international trial will enroll patients with metastatic or locally advanced unrespectable soft tissue sarcoma who have not received chemotherapy other then the adjuvant or neoadjuvant setting. The trial has been designed to evaluate the capability and the safety of TH-302 in combination with doxorubicin, in comparison to just doxorubicin alone. Succeeding an end of Phase 2 meeting with the FDA, the Phase 3 protocol has been…

Continue Reading

FridaySep 30, 2011 3:27 pm

Intellect Neurosciences (ILNS), ViroPharma (VPHM) Ink Licensing Agreement

Intellect Neurosciences Inc. today announced it has granted an exclusive license to ViroPharma Inc., in which the company will receive licensed patents and patent applications related to Intellect's orally administered, clinical stage drug candidate, OX1. ViroPharma plans to develop and commercialize OX1 to treat Friedreich's Ataxia, a disease that causes nervous system damages and affects movement, as well as for the treatment of diseases for which OX1 may qualify for orphan drug designation. "We are pleased to enter into a strategic relationship with ViroPharma, which has ample resources, drug development capabilities and orphan drug marketing expertise to accelerate the development…

Continue Reading

FridaySep 30, 2011 2:49 pm

BeaconEquity.com: DoJ Investigation of 9 Chinese Companies triggers Sell-off

Chinese companies trading on North American exchanges are once again in the regulatory spotlight; this time, it’s the Chinese Internet companies that are under fire. According to reports, the U.S. Justice Department (DoJ) is investigating possible accounting frauds at a number of Chinese Internet companies trading on U.S. exchanges, which isn’t too much of a surprise considering swelling speculation regarding the legitimacy of Chinese stocks. Keep your eye on these guys and trade at your own risk: SINA Corp. (NASDAQ: SINA), Baidu.com Inc. (ADR) (NASDAQ: BIDU), Yoku.com Inc. (NYSE: YOKU), Focus Media (NASDAQ: FMCN), Sohu.com Inc. (NASDAQ: SOHU), Ctrip.com (NASDAQ:…

Continue Reading

FridaySep 30, 2011 2:44 pm

BeaconEquity.com: Here’s Why the Gold Price Goes Higher

In his latest interview with King World News, Euro Pacific Capital CEO said the U.S. economy is dropping quickly, gold will go much higher as a result of his bleak outlook, and the U.S. Treasury market is not a permanent safe haven for investors seeking shelter from market volatility brought on by sovereign bailouts, which, he added, will move across the Atlantic to the United States. “We are going to fall off the edge of a cliff; it’s just a different cliff than most people are looking for,” Schiff told King World News’ Eric King. “I don’t think the stock…

Continue Reading

FridaySep 30, 2011 11:28 am

Universal Bioenergy (UBRG) Plans for OTC Bulletin Board Listing

Universal Bioenergy Inc. is an independent, diversified energy company that is focused on producing and marketing natural and alternative energy products, including natural gas, petroleum, biofuels, synthetic fuels, wind, solar and related energy technology products. The company today announced plans to be listed on the Over the Counter Bulletin Board (OTCBB) in order to expand its shareholder base and attract institutional investors. Universal Bioenergy has engaged the services of a financial consultant and a broker dealer/market maker to assist with the application and approval process. The OTC Bulletin Board is a quotation service that displays real-time quotes, last sale prices,…

Continue Reading

FridaySep 30, 2011 10:17 am

SunOpta Inc. (STKL) Expands Aseptic Drink Capacity to Meet Increased Demand for Organic Beverages

SunOpta Inc., a leading global company focused on natural, organic and specialty foods and natural health products, announced that it is expanding its non-dairy beverage production operations to meet the growing demand for aseptic, non-dairy beverages, broths and soups. SunOpta said that the expansion of the company's Modesto, California plant will help meet the needs of existing clients plus accommodate the production of new private label, non-dairy, aseptic beverages planned to launch with a large club format retailer early next year. SunOpta specializes in processing, sourcing and packaging natural and organic foods like soy, sunflower, corn, fiber and fruit. The…

Continue Reading

FridaySep 30, 2011 10:04 am

Midas Medici Group Holdings, Inc. (MMED) Aims for Senior U.S. Exchange

Midas Medici, a green-oriented IT solutions provider, announced today that it is actively seeking a listing on a senior U.S. stock exchange (NASDAQ or AMEX), once the company meets all applicable listing requirements. The move is meant to increase the company’s visibility in U.S. capital markets, and is a key part of their overall high-growth strategy. Midas CEO and co-founder, Mr. Nana Baffour, commented on the announcement. “Graduating to a senior U.S. exchange is a high priority for Midas given the tremendous progress we have made growing our business through a combination of organic growth and accretive acquisitions in the…

Continue Reading

FridaySep 30, 2011 9:58 am

Horizon Pharma, Inc. (HZNP) Appoints Grey and Pauli to Board of Directors

Located in Northbrook, Illinois, Horizon Pharma is a biopharmaceutical company that commercializes innovative medicine that targets the unmet therapeutic needs in arthritis, pain and inflammatory diseases. Today, Horizon took another step forward with the announcement they have appointed industry veterans Michael Grey and Ronald Pauli to their Board of Directors. Michael Grey received his bachelor’s degree in chemistry from the University of Nottingham in the United Kingdom. Since then, Grey has had an impressive career. Grey currently serves as president and chief executive officer at Lumena Pharmaceuticals, Inc. In a career that has spanned more than 3 decades, he has…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered